IP Library › Granted Patent US 8,088,827
Granted Patent B2
US 8,088,827 · App. 12/477,562 · Granted Jan 3, 2012

Use of irbesartan for the preparation of medicinal products that are useful for treating pulmonary hypertension

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,088,827
App. No.
12/477,562
Granted
Jan 3, 2012
Kind
B2
Abstract

The present invention relates to the use of irbesartan for the preparation of medicinal products that are useful for preventing or treating pulmonary arterial hypertension or pulmonary hypertension.

Claims (2)

1. A method for treating pulmonary arterial hypertension or pulmonary hypertension, the method comprising administering to a patient in need of such treatment an effective amount of irbesartan.

2. The method according to claim 1 , wherein said irbesartan is combined with hydrochlorothiazide.

Assignments (3)
CHANGE OF NAME Recorded Jun 20, 2012
From: SANOFI-AVENTIS
To: SANOFI
Reel/Frame 028413/0927 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2012
From: COSNIER-PUCHEU, SYLVIE; NISATO, DINO; ROCCON, ALAIN
To: SANOFI-SYNTHELABO
Reel/Frame 028180/0645 →
CHANGE OF NAME Recorded May 9, 2012
From: SANOFI-SYNTHELABO
To: SANOFI-AVENTIS
Reel/Frame 028184/0805 →